RAYMOND JAMES & ASSOCIATES - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 51 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q1 2022$18,000
+28.6%
22,000
+63.0%
0.00%
Q4 2021$14,000
+27.3%
13,500
-20.6%
0.00%
Q3 2019$11,0000.0%17,000
+36.0%
0.00%
Q2 2019$11,000
-88.8%
12,500
-64.7%
0.00%
Q1 2017$98,00035,4400.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,207,337$2,903,0000.90%
COURAGE CAPITAL MANAGEMENT LLC 331,846$211,0000.46%
Arkadios Wealth Advisors 1,399,000$890,0000.14%
Kingsbury Capital Investment Advisors LLC 119,949$76,0000.12%
NEVILLE RODIE & SHAW INC 1,753,500$1,115,0000.11%
JTC Employer Solutions Trustee Ltd 775,000$508,0000.08%
Platform Technology Partners 162,410$103,0000.06%
Main Street Financial Solutions, LLC 400,826$255,0000.04%
National Wealth Management Group, LLC 46,000$29,2560.04%
STALEY CAPITAL ADVISERS INC 1,200,000$764,0000.02%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders